funder-graph

FundersNYAlzheimer's Drug Discovery Foundation › 2024

Grants paid by Alzheimer's Drug Discovery Foundation, tax year 2024

EIN 20-1082179 · New York, NY · Form 990, Schedule I · NTEE V36

In tax year 2024, Alzheimer's Drug Discovery Foundation (EIN 20-1082179) reported 26 grants paid totaling $54,800,524. Dataset version 2026.09.0, built 2026-09-03.

20192020202220232024

Every grant, 2024

Grants reported by Alzheimer's Drug Discovery Foundation for tax year 2024
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Alamar Biosciences Fremont, CAA$10,016,094paidALZHEIMERS RESEARCH202533159349302688
2024C2n Diagnostics St Louis, MOA$7,025,121paidALZHEIMERS RESEARCH202533159349302688
2024Pharmatrophix Menlo Park, CAA$5,609,700paidALZHEIMERS RESEARCH202533159349302688
2024Coya Therapeutics Houston, TXA$5,000,000paidALZHEIMERS RESEARCH202533159349302688
2024Metro International Biotechedenroc Cambridge, MAA$5,000,000paidALZHEIMERS RESEARCH202533159349302688
2024Modulo Bio Inc San Diego, CAA$4,845,794paidALZHEIMERS RESEARCH202533159349302688
2024University of Nevada Las Vegas Las Vegas, NVA$3,247,762paidALZHEIMERS RESEARCH202533159349302688
2024Aquinnah Pharmaceuticals Cambridge, MAA$2,999,586paidALZHEIMERS RESEARCH202533159349302688
2024Davos Alzheimers Collaborative Philadelphia, PAA$2,500,000paidALZHEIMERS RESEARCH202533159349302688
2024University of Arizona - Health Sciences Tucson, AZA$1,774,201paidALZHEIMERS RESEARCH202533159349302688
2024Vaccinex Rochester, NYA$1,750,000paidALZHEIMERS RESEARCH202533159349302688
2024Viewmind New York, NYA$1,429,119paidALZHEIMERS RESEARCH202533159349302688
2024Esya Inc Frisco, TXA$789,000paidALZHEIMERS RESEARCH202533159349302688
2024Trustees of Indiana University Bloomington, INA$599,920paidALZHEIMERS RESEARCH202533159349302688
2024University of Minnesota Brookline, MAA$493,875paidALZHEIMERS RESEARCH202533159349302688
2024Clearview Healthcare Partners New York, NYA$272,000paidALZHEIMERS RESEARCH202533159349302688
2024Johns Hopkins University Baltimore, MDA$269,967paidALZHEIMERS RESEARCH202533159349302688
2024Neurotherapia Inc Gates Mills, OHA$250,000paidALZHEIMERS RESEARCH202533159349302688
2024University of Kansas Medical Center Kansas City, KSA$250,000paidALZHEIMERS RESEARCH202533159349302688
2024Neuroage Therapeutics San Francisco, CAA$249,817paidALZHEIMERS RESEARCH202533159349302688
2024Mti Biotech Inc Ames, IAA$158,576paidALZHEIMERS RESEARCH202533159349302688
2024Trustees of Boston University Boston, MAA$150,000paidALZHEIMERS RESEARCH202533159349302688
2024Usagainstalzheimer's Network Washington, DCA$65,000paidALZHEIMERS RESEARCH202533159349302688
2024The Milken Institute New York, NYA$25,000paidALZHEIMERS RESEARCH202533159349302688
2024Global Alzheimer's Platform Foundation Washington, DCA$20,000paidALZHEIMERS RESEARCH202533159349302688
2024Mobility Consulting Group LLC Alpharetta, GAA$9,992paidALZHEIMERS RESEARCH202533159349302688

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.